Biotech Values

[AlohaDan]

Thanks Dew

Some ramblings & questions on GTCB

First DTCG at the ManuPharma presence got the brain cells thinking.

I was somewhat familar with Laureate Pharma due to DSCO connection.

The way I interpret their agreement is that while ATryn might be involved this is more a production agreement for producing proteins for other companies. While Laureate is certainly a GMP certified facility for other drugs doesn't this imply GMP production using DTCG goats as the protein "production machine" with Laureate doing the end point purification? And from here their belief the FDA will approve? You have them producing(it sounds like) Merrimack and Centracor drugs. So what are the odds the FDA approves this method of protein production?

Another question if you don't mind. The Laureate Pharma agreement seems to fly in the face of their restructuring announcement of Feb 24th"FRAMINGHAM, MA - February 4, 2004 -- GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today that it is restructuring its organization to support its focus on clinical development and commercialization of its internal pipeline of proprietary products and its portfolio of external programs. GTC's internal pipeline of products includes ATryn®, recombinant human serum albumin, and the MSP-1 malaria vaccine.

Does this mean no new proteins and completing only present deals like Centracor? I'm a little lost here on their true business plan.

And in conclusion I take it from the GTCB Yahoo board your pretty much in agreement with Norman Klien's assessment of Atryn approval path in Europe?

I bought some at $2.30, but am still trying to pin down whether to put $ here or elsewhere.

TIA